Osang Healthcare Co., Ltd. (036220)

Overview

Osang Healthcare Co., Ltd is a South Korean company deeply entrenched in the medical diagnostics sector, with its efforts focused on the research, development, and international sale of diagnostic biosensors. Founded in 1996 and originally operating under the name Infopia Co., Ltd, the company underwent a rebranding in April 2017, adopting its current name. Osang Healthcare has established a remarkable global footprint, exporting its products to around 110 countries. The company’s headquarters are situated in Anyang, South Korea, serving as a hub for its innovative endeavors in transforming healthcare diagnostics.

Products and Services

Osang Healthcare Co.,Ltd is dedicated to offering an extensive range of diagnostic biosensors tailored to meet diverse healthcare needs. Its product lineup includes:

• Blood Glucose Biosensors: These devices are designed for the accurate monitoring of blood glucose levels, catering to the needs of diabetic patients for regular blood sugar management.
• Hemoglobin A1c Biosensors: Targeting the measurement of average blood glucose concentration over approximately three months, these biosensors are crucial for diabetes management and control.
• Cholesterol Biosensors: Enabling the measurement of cholesterol levels, these biosensors are vital for assessing cardiovascular health and managing risks associated with heart disease.
• Immuno Diagnosis: This category includes biosensors and diagnostic tools for the detection of various immunological markers, aiding in the diagnosis of autoimmune diseases, infections, and other immune-related conditions.
• Molecular Diagnosis: Osang Healthcare extends its expertise to molecular diagnostics, providing sophisticated tools for the detection and analysis of genetic material from pathogens, playing a pivotal role in identifying various diseases at the molecular level.